Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis
This study has been completed.
Study NCT00666185   Information provided by Astellas Pharma Inc
First Received: April 22, 2008   Last Updated: June 26, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Candidiasis, Oral
Additional conditions recognized in this trial
Candidiasis
Esophageal Diseases
More general conditions related to this trial
Digestive System Diseases
Gastrointestinal Diseases
Mouth Diseases
Mycoses
Stomatognathic Diseases
Interventions listed in this trial
Micafungin
Fluconazole
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Astellas Pharma Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services